Akero Therapeutics Inc (AKRO)
29.76
-1.21
(-3.91%)
USD |
NASDAQ |
Nov 14, 16:00
29.02
-0.74
(-2.49%)
After-Hours: 20:00
Akero Therapeutics Free Cash Flow: -212.64M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -212.64M |
| June 30, 2024 | -191.94M |
| March 31, 2024 | -155.88M |
| December 31, 2023 | -145.37M |
| September 30, 2023 | -122.25M |
| June 30, 2023 | -97.15M |
| March 31, 2023 | -94.27M |
| December 31, 2022 | -92.52M |
| September 30, 2022 | -93.70M |
| June 30, 2022 | -83.69M |
| March 31, 2022 | -84.21M |
| December 31, 2021 | -79.68M |
| Date | Value |
|---|---|
| September 30, 2021 | -76.39M |
| June 30, 2021 | -75.43M |
| March 31, 2021 | -77.98M |
| December 31, 2020 | -70.95M |
| September 30, 2020 | -59.20M |
| June 30, 2020 | -58.76M |
| March 31, 2020 | -41.50M |
| December 31, 2019 | -35.63M |
| September 30, 2019 | -26.05M |
| June 30, 2019 | -14.80M |
| March 31, 2019 | -14.73M |
| December 31, 2018 | -4.625M |
Free Cash Flow Range, Past 5 Years
-212.64M
Minimum
Sep 2024
-35.63M
Maximum
Dec 2019
-97.46M
Average
-83.95M
Median
Free Cash Flow Benchmarks
| Madrigal Pharmaceuticals Inc | -438.32M |
| 89bio Inc | -280.54M |
| NovaBay Pharmaceuticals Inc | -4.812M |
| Palatin Technologies Inc | -31.50M |
| iBio Inc | -18.55M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -70.42M |
| Cash from Investing (Quarterly) | 73.07M |
| Cash from Financing (Quarterly) | 3.067M |
| Free Cash Flow Per Share (Quarterly) | -1.014 |
| Free Cash Flow Yield | -11.27% |